Atlas Trials

A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer

Clinical trial NCT03017404 · COMPLETED

Trial details

NCT number
NCT03017404
Sponsor
Hebei Medical University Fourth Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2015-05-01
Primary completion
2016-05-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.